Pfizer launches Toviaz in the US
This article was originally published in Scrip
Executive Summary
Pfizer has introduced its overactive bladder therapy Toviaz (fesoterodine fumarate) extended-release in the US, having gained approval for it in October last year (scripnews.com, November 3rd, 2008).